- Home
- OCGN vs ODV Comparison
OCGN vs ODV Comparison
Compare OCGN & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- ODV
- Stock Information
- Founded
- OCGN 2013
- ODV 2005
- Country
- OCGN United States
- ODV Canada
- Employees
- OCGN N/A
- ODV N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- ODV Precious Metals
- Sector
- OCGN Health Care
- ODV Basic Materials
- Exchange
- OCGN Nasdaq
- ODV Nasdaq
- Market Cap
- OCGN 252.4M
- ODV 204.7M
- IPO Year
- OCGN N/A
- ODV N/A
- Fundamental
- Price
- OCGN $0.91
- ODV $1.82
- Analyst Decision
- OCGN Strong Buy
- ODV
- Analyst Count
- OCGN 3
- ODV 0
- Target Price
- OCGN $5.67
- ODV N/A
- AVG Volume (30 Days)
- OCGN 4.3M
- ODV 379.0K
- Earning Date
- OCGN 11-08-2024
- ODV 11-12-2024
- Dividend Yield
- OCGN N/A
- ODV N/A
- EPS Growth
- OCGN N/A
- ODV N/A
- EPS
- OCGN N/A
- ODV N/A
- Revenue
- OCGN $4,700,000.00
- ODV $8,487,361.00
- Revenue This Year
- OCGN N/A
- ODV N/A
- Revenue Next Year
- OCGN N/A
- ODV $239.72
- P/E Ratio
- OCGN N/A
- ODV N/A
- Revenue Growth
- OCGN N/A
- ODV N/A
- 52 Week Low
- OCGN $0.36
- ODV $1.34
- 52 Week High
- OCGN $2.11
- ODV $3.19
- Technical
- Relative Strength Index (RSI)
- OCGN 44.59
- ODV 51.86
- Support Level
- OCGN $0.85
- ODV $1.39
- Resistance Level
- OCGN $0.94
- ODV $2.02
- Average True Range (ATR)
- OCGN 0.08
- ODV 0.13
- MACD
- OCGN -0.01
- ODV 0.03
- Stochastic Oscillator
- OCGN 19.64
- ODV 70.63
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation and development activities of its projects.